These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39051710)

  • 21. Charcot-Marie-Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study.
    Berciano J; Gallardo E; García A; Infante J; Mateo I; Combarros O
    J Neurol Neurosurg Psychiatry; 2006 Oct; 77(10):1169-76. PubMed ID: 16788010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A novel mutation in glycyl-tRNA synthetase caused Charcot-Marie-Tooth disease type 2D with facial and respiratory muscle involvement].
    Kawakami N; Komatsu K; Yamashita H; Uemura K; Oka N; Takashima H; Takahashi R
    Rinsho Shinkeigaku; 2014; 54(11):911-5. PubMed ID: 25420567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infantile-onset CMT2D/dSMA-V in a Chinese family with parental germline mosaicism for a novel mutation in the GARS1 gene.
    Huang Y; Bi B; Zhao P; Yu T; Luo S; Tan L; Liu Z; Liu J; He X
    Mol Genet Genomic Med; 2022 Jan; 10(1):e1846. PubMed ID: 34898052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot phenotype and natural history study of hereditary neuropathies caused by mutations in the HSPB1 gene.
    Rossor AM; Morrow JM; Polke JM; Murphy SM; Houlden H; ; Laura M; Manji H; Blake J; Reilly MM
    Neuromuscul Disord; 2017 Jan; 27(1):50-56. PubMed ID: 27816334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NEFL N98S mutation: another cause of dominant intermediate Charcot-Marie-Tooth disease with heterogeneous early-onset phenotype.
    Berciano J; Peeters K; García A; López-Alburquerque T; Gallardo E; Hernández-Fabián A; Pelayo-Negro AL; De Vriendt E; Infante J; Jordanova A
    J Neurol; 2016 Feb; 263(2):361-369. PubMed ID: 26645395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered TDP-43-dependent splicing in HSPB8-related distal hereditary motor neuropathy and myofibrillar myopathy.
    Cortese A; Laurà M; Casali C; Nishino I; Hayashi YK; Magri S; Taroni F; Stuani C; Saveri P; Moggio M; Ripolone M; Prelle A; Pisciotta C; Sagnelli A; Pichiecchio A; Reilly MM; Buratti E; Pareyson D
    Eur J Neurol; 2018 Jan; 25(1):154-163. PubMed ID: 29029362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotype of Charcot-Marie-Tooth disease Type 2.
    Bienfait HM; Baas F; Koelman JH; de Haan RJ; van Engelen BG; Gabreëls-Festen AA; Ongerboer de Visser BW; Meggouh F; Weterman MA; De Jonghe P; Timmerman V; de Visser M
    Neurology; 2007 May; 68(20):1658-67. PubMed ID: 17502546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel WARS mutation (p.Asp314Gly) identified in a Chinese distal hereditary motor neuropathy family.
    Wang B; Li X; Huang S; Zhao H; Liu J; Hu Z; Lin Z; Liu L; Xie Y; Jin Q; Zhao H; Tang B; Niu Q; Zhang R
    Clin Genet; 2019 Aug; 96(2):176-182. PubMed ID: 31069783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel HSPB1 mutation in an Italian patient with CMT2/dHMN phenotype.
    Luigetti M; Fabrizi GM; Madia F; Ferrarini M; Conte A; Del Grande A; Tasca G; Tonali PA; Sabatelli M
    J Neurol Sci; 2010 Nov; 298(1-2):114-7. PubMed ID: 20870250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical, pathological and genetic characteristics of 8 patients with distal hereditary motor neuropathy].
    Liu MG; Fang P; Wang Y; Cong L; Fan YY; Yuan Y; Xu Y; Zhang J; Hong DJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 53(5):957-963. PubMed ID: 34650302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and clinical profile of 15 Chinese families with GDAP1-related Charcot-Marie-Tooth disease and identification of H256R as a frequent mutation.
    Li Z; Zeng S; Xie Y; Li X; Huang S; Zhao H; Cao W; Liu L; Wang M; Gong Q; Liu J; Rong P; Zhang R
    J Peripher Nerv Syst; 2024 Jun; 29(2):232-242. PubMed ID: 38705839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A/C.
    Tazir M; Azzedine H; Assami S; Sindou P; Nouioua S; Zemmouri R; Hamadouche T; Chaouch M; Feingold J; Vallat JM; Leguern E; Grid D
    Brain; 2004 Jan; 127(Pt 1):154-63. PubMed ID: 14607793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic correlations in a large single-center cohort of patients with BSCL2 nerve disorders: a clinical, neurophysiological and muscle magnetic resonance imaging study.
    Fernández-Eulate G; Fernández-Torrón R; Guisasola A; Gaspar MTI; Diaz-Manera J; Maneiro M; Zulaica M; Olasagasti V; Formica AF; Espinal JB; Ruiz M; Schlüter A; Pujol A; Poza JJ; López de Munain A
    Eur J Neurol; 2020 Aug; 27(8):1364-1373. PubMed ID: 32320108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Charcot-Marie-Tooth type 2 and distal hereditary motor neuropathy: Clinical, neurophysiological and genetic findings from a single-centre experience.
    Luigetti M; Fabrizi GM; Bisogni G; Romano A; Taioli F; Ferrarini M; Bernardo D; Rossini PM; Sabatelli M
    Clin Neurol Neurosurg; 2016 May; 144():67-71. PubMed ID: 26989944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alanyl-tRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy.
    Zhao Z; Hashiguchi A; Hu J; Sakiyama Y; Okamoto Y; Tokunaga S; Zhu L; Shen H; Takashima H
    Neurology; 2012 May; 78(21):1644-9. PubMed ID: 22573628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, neurophysiological and morphological study of dominant intermediate Charcot-Marie-Tooth type C neuropathy.
    Thomas FP; Guergueltcheva V; Gondim FA; Tournev I; Rao CV; Ishpekova B; Kinsella LJ; Pan Y; Geller TJ; Litvinenko I; De Jonghe P; Scherer SS; Jordanova A
    J Neurol; 2016 Mar; 263(3):467-76. PubMed ID: 26725087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy.
    Claeys KG; Züchner S; Kennerson M; Berciano J; Garcia A; Verhoeven K; Storey E; Merory JR; Bienfait HM; Lammens M; Nelis E; Baets J; De Vriendt E; Berneman ZN; De Veuster I; Vance JM; Nicholson G; Timmerman V; De Jonghe P
    Brain; 2009 Jul; 132(Pt 7):1741-52. PubMed ID: 19502294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spinal Charcot-Marie-Tooth disease: a reappraisal.
    Devic P; Petiot P; Mauguière F
    Muscle Nerve; 2012 Oct; 46(4):604-9. PubMed ID: 22987707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.